Structure Therapeutics (GPCR) Earnings Date & Reports

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GPCR is expected to report earnings to fall 3.70% to -25 cents per share on August 07

Structure Therapeutics GPCR Stock Earnings Reports

Q2'25

Est.

$-0.26

Q1'25

Missed

by $0.02

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.06

The last earnings report on May 08 showed earnings per share of -27 cents, missing the estimate of -25 cents. With 424.60K shares outstanding, the current market capitalization sits at 1.37B.

View a ticker or compare two or three

Compare

GPCR